相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor treating fields cause replication stress and interfere with DNA replication fork maintenance: Implications for cancer therapy
Narasimha Kumar Karanam et al.
TRANSLATIONAL RESEARCH (2020)
Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
Wenyin Shi et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
Ulrich Herrlinger et al.
LANCET (2019)
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
Denise Fabian et al.
CANCERS (2019)
Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial
Matthew T. Ballo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
EXTH-02. THE BLOOD BRAIN BARRIER (BBB) PERMEABILITY IS ALTERED BY TUMOR TREATING FIELDS (TTFIELDS) IN VIVO
Ellina Schulz et al.
NEURO-ONCOLOGY (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial
S. A. Toms et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial
Giovanni L. Ceresoli et al.
LANCET ONCOLOGY (2019)
Cellular origin of glioblastoma and its implication in precision therapy
Maojin Yao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma A Secondary Analysis of a Randomized Clinical Trial
Martin J. B. Taphoorn et al.
JAMA ONCOLOGY (2018)
TUMOR TREATING FIELDS TECHNOLOGY: ALTERNATING ELECTRIC FIELD THERAPY FOR THE TREATMENT OF SOLID TUMORS
Laura Benson
SEMINARS IN ONCOLOGY NURSING (2018)
P04.59 Modeling the safety of topical agents for skin toxicity associated with tumor treating fields therapy in glioblastoma
M Lacouture et al.
NEURO-ONCOLOGY (2018)
Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations
Anders Rosendal Korshoej et al.
PLOS ONE (2018)
INNV-01. PROTECT STUDY: PROPHYLACTIC SKIN TOXICITY THERAPY WITH CLINDAMYCIN AND CLOBETASOL OR SKIN BARRIER IN GLIOBLASTOMA PATIENTS TREATED WITH TUMOR TREATING FIELDS
Mario Lacouture
NEURO-ONCOLOGY (2018)
INNV-03. SAFETY AND ADVERSE EVENT PROFILE OF TUMOR TREATING FIELDS USE IN THE EMEA REGION A REAL-WORLD DATA ANALYSIS
Sied Kebir et al.
NEURO-ONCOLOGY (2018)
AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
Anna Shteingauz et al.
CELL DEATH & DISEASE (2018)
Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
Bryan G. Harder et al.
FRONTIERS IN ONCOLOGY (2018)
Tumor treating fields increases membrane permeability in glioblastoma cells
Edwin Chang et al.
CELL DEATH DISCOVERY (2018)
IRRITANT AND ALLERGIC CONTACT DERMATITIS - SKIN LESION CHARACTERISTICS
Gaby Novak-Bilic et al.
ACTA CLINICA CROATICA (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
Myra E. van Linde et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Skin toxicities associated with tumor treating fields: case based review
Rimas V. Lukas et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
ACTR-10. PATTERNS OF TTFIELDS-RELATED SEVERE SKIN TOXICITY IN GBM PATIENTS
Frank Lieberman et al.
NEURO-ONCOLOGY (2017)
QLIF-36. ROLE OF NURSES FOR THE IMPLEMENTATION OF TTFIELDS IN DAILY CLINICAL ROUTINE IN GLIOBLASTOMA TREATMENT
Mandy Kilias et al.
NEURO-ONCOLOGY (2017)
ACTR-11. OVERALL SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH OPTUNE® CORRELATES WITH COMPLIANCE: CONSISTENCY ACROSS STUDIES
Wyatt Potter et al.
NEURO-ONCOLOGY (2017)
Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells
Moshe Giladi et al.
RADIATION ONCOLOGY (2017)
Advances in Brain Tumor Surgery for Glioblastoma in Adults
Montserrat Lara-Velazquez et al.
BRAIN SCIENCES (2017)
Tumor Treating Fields (TTFields) plus anti-PD-1 therapy induce immunogenic cell death resulting in enhanced antitumor efficacy
Tali Voloshin et al.
CANCER RESEARCH (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
Don S. Dizon et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis
Eun Ho Kim et al.
ONCOTARGET (2016)
Optune®: Practical Nursing Applications
Janlyn Murphy et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)
Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy
Marlon Garzo Saria et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)
QOL-09EFFECT OF ANTIPERSPIRANTS AND SKIN BARRIERS ON ELECTRICAL RESISTANCE DURING TTFIELDS APPLICATION
Roni Blat et al.
NEURO-ONCOLOGY (2015)
NovoTTF™-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL™ system user study
Aafia Chaudhry et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells
Moshe Giladi et al.
SCIENTIFIC REPORTS (2015)
Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
Dennis L. Stevens et al.
CLINICAL INFECTIOUS DISEASES (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma
Mario E. Lacouture et al.
SEMINARS IN ONCOLOGY (2014)
Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe)
Maciej M. Mrugala et al.
SEMINARS IN ONCOLOGY (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Many Paths to Alopecia via Compromised Regeneration of Hair Follicle Stem Cells
Ji Li et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Roger Stupp et al.
EUROPEAN JOURNAL OF CANCER (2012)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors
Eilon D. Kirson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Disruption of cancer cell replication by alternating electric fields
ED Kirson et al.
CANCER RESEARCH (2004)
分享论文
